Complete Blood Count (CBC)
This test measures the amount of amino beta guanidinopropionate, a guanidine compound, in your urine to help evaluate certain metabolic conditions.
{"The test analyzes a urine sample to detect amino beta guanidinopropionate levels","It helps doctors evaluate kidney function and certain metabolic disorders","Results are reported as present/absent rather than numerical values","The test requires a simple urine collection","Abnormal results may indicate kidney problems or specific metabolic conditions"}
Key facts at a glance
- LOINC
- 12471-9
- Short code
- ABGPU
- Synonyms
- AB-Gp Ur-mCnc
- Category
- chemistry
- Sample
- urine
- Container
- Sterile plastic urine container (without preservatives)
- Units
- N/A
- Ref low
- 0
- Ref high
- 5
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- ≥ 0 years
- Method
- Liquid chromatography-tandem mass spectrometry (LC-MS/MS)
- CPT
- 82131
- SNOMED
- 274517006
- Specimen volume
- Minimum 5 mL, preferred 10 mL urine
- Stability
- Refrigerate at 2-8°C for up to 7 days. For longer storage, freeze at -20°C or below. Avoid repeated freeze-thaw cycles.
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 72–168 hours
- Order
- routine
A complete blood count, or CBC, is a common blood test that measures the different cells in your blood, including red blood cells, white blood cells, and platelets. It gives your doctor a broad picture of your overall health and can help detect a wide range of conditions.
The urine amino beta guanidinopropionate test is a specialized laboratory test that detects the presence of amino beta guanidinopropionate in your urine. Amino beta guanidinopropionate is a compound related to guanidine, which is a substance that can be produced by the body during normal metabolism or may be introduced through certain exposures. This test is typically ordered to help evaluate kidney function and detect certain metabolic disorders.
The test is performed by drawing a small sample of blood, usually from a vein in your arm. A healthcare professional will clean the site, insert a thin needle, and collect the blood into a tube. The procedure takes only a few minutes, and you can typically return to your normal activities right away.
This test requires a urine sample. You will be given a sterile container to collect a sample of your urine. For most accurate results, you may be asked to collect the first morning urine sample, as it is more concentrated. The sample is then sent to a laboratory where it is analyzed using specialized techniques to detect the presence and amount of amino beta guanidinopropionate.
Your doctor may order this test as part of a routine checkup, to investigate symptoms such as fatigue, weakness, fever, or easy bruising, or to monitor an existing condition such as anemia, infection, or a blood disorder. It is also used to follow how certain treatments, like chemotherapy, affect your blood cells.
Your doctor may order this test if you have symptoms suggesting a kidney problem or a metabolic disorder. It may also be used to monitor certain conditions or to evaluate the effectiveness of treatment. The test helps healthcare providers understand how well your kidneys are filtering waste products from your blood.
Your results will show whether your blood cell counts fall within normal ranges. High or low values can point to conditions such as anemia, infection, inflammation, or clotting problems, but a single abnormal value does not always mean you are ill. Your doctor will interpret the numbers alongside your symptoms and medical history and discuss what they mean for you.
Results for this test are typically reported as positive (present) or negative (not detected). A positive result means that amino beta guanidinopropionate was found in your urine, which may indicate that your kidneys are not filtering this compound properly, or that there is an underlying metabolic condition. Your doctor will interpret the results in the context of your overall health, symptoms, and other test results.
Reference range
Reference range varies by laboratory and method. Typically 0-5 mmol/mol creatinine for amino beta guanidinopropionate in urine. Consult laboratory-specific reference intervals.N/A
No special preparation required. Collect random urine sample. Inform laboratory of any supplements or medications that may affect guanidino compound metabolism.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
The presence of amino beta guanidinopropionate in urine may indicate impaired kidney function, as healthy kidneys typically filter out these compounds effectively. This test can help detect renal tubular disorders or other conditions affecting kidney function. It may also be used in the evaluation of certain inherited metabolic disorders where guanidine compounds accumulate in the body.
Abnormal results may prompt further testing to determine the underlying cause. Your healthcare provider will consider this test result along with other clinical findings, laboratory tests, and your medical history to make a diagnosis and develop an appropriate treatment plan.
Frequently asked questions
Do I need to fast before this test?
Are there any risks associated with this test?
How long does it take to get results?
What happens if my results are abnormal?
Sources
- 1
- 2
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy